Event Description The pandemic has accelerated trends moving the delivery of care into the home or community. Yet, care at home largely remains the province of better resourced individuals, due to limited funding by government programs. Medicaid, the federal/state program of health care for people of lower income, has the potential to address these equity…
Event Description The legalization of cannabis has raised significant questions for law and public policy. In this public event, neuroscientist Dr. Yasmin Hurd exploref the science of cannabis, CBD, and the future of substance use disorder treatment. Dr. Stephanie Tabashneck then moderated a discussion and audience Q&A about the implications for law and policy. Panelists Media…
Event Description Microdosing psychedelics involves consuming doses that are one-twentieth to one-tenth the size of standard doses. The practice has become increasingly popular among individuals seeking to boost their productivity, elevate their mood, or treat symptoms of depression, anxiety, or pain. The increasing use of microdosing has inspired media coverage and scientific analysis of its…
Confronting pandemics and improving health in low-income countries requires ambitious public health plans. Global health responses to HIV/AIDS and multidrug resistant tuberculosis can provide guidance on how to garner public support and gain financial and political commitments to implement large-scale public health interventions and systems. In this session, experts discussed what it takes to finance…
Event Description The jurisprudence of the Inter-American Court of Human Rights has been profoundly influential in the region since its inception in 1979. Since 2017, the Court has built up case law on the right to health, addressing an array of issues including: access to emergency care, HIV treatment, and health services for prison inmates;…
Event Description In Commonwealth v. Eldred, the Massachusetts Supreme Judicial Court held that a court may order a defendant who is addicted to substances to remain drug free as a condition of probation and that if a defendant tests positive for an illegal substance, the defendant may be found in violation of his or her…
Event Description As the psychedelic renaissance unfolds, groups are forming to identify national policy priorities. This event assembled a panel of experts from several of these groups for a discussion on setting a national psychedelic policy agenda. Panelists Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.
Event Description Incarcerated people in the U.S. suffer disproportionately from chronic health conditions, their acute medical needs often go unmet, and the carceral healthcare system that serves them is set up to fail by a lack of resources and infrastructure. The pandemic has only magnified the health crisis that is the norm in the U.S….
Event Description The psychedelic renaissance is characterized by growing interest in researching, commercializing, and consuming psychedelic substances like psilocybin and dimethyltryptamine (DMT). Against this backdrop, a wave of psychedelic legal reform is washing over North America. A dozen U.S. cities have decriminalized psychedelics, and about a dozen U.S. states have proposed laws to legalize these…
Event Description Psychedelic substances such as psilocybin, MDMA, and ketamine are being used increasingly in research and clinical settings. They also are being decriminalized and legalized by cities and states across the country. As research and access advance, a growing body of evidence suggests that one promising application for psychedelics is in the treatment of…
